US Patent 11905329 Anti-PD-1 antibodies and uses thereof
Patent 11905329 was granted and assigned to Jounce Therapeutics, Inc. on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+218 characters)
US Patent 11905329 Anti-PD-1 antibodies and uses thereof
Article
Patent abstract
Provided herein are various embodiments relating to antibodies. Some of the embodiments include antagonist antibodies that bind PD-1. Such antibodies can be used in methods to treat, for example, cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
George Robert Mabry, III0
Stephen Sazinsky0
Date of Patent
February 20, 2024
0Patent Application Number
178342370
Date Filed
June 7, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11905329 Anti-PD-1 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
